Ipsen and Marengo Therapeutics announce strategic

Multi-year collaboration will sustain Ipsen’s presence in oncology by leveraging Marengo’s novel discovery of TCR Vβ-targeted precision T cell activation...

Related Keywords

United States ,Saclay ,France General ,France ,Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,China ,Paris ,Shanghai ,American ,Denise Reid Bashir ,Howard Mayer ,Ioana Piscociu ,Ipsen Euronext ,Zhen Su ,Svetlana Makhni ,Development Communications ,Marengo Therapeutics Inc ,Verge Scientific Communications ,Marengo Therapeutics ,Investigational New Drug ,Executive Vice President ,Rare Disease ,With Specialty Care ,Sponsored Level ,American Depositary Receipt ,Selectivet Cell Activation Repertoire ,French Autorit ,Des March ,Registration Document ,Global Media ,Paris Stock Exchange Ipn ,Ipsen Sa ,